CLINICAL RESEARCH TESTING SERVICES

Brand Owner (click to sort) Address Description
EXTENSYN QUINTILES TRANSNATIONAL CORP. 4820 Emperor Boulevard Durham NC 27703 Clinical research and testing services in the fields of pharmaceuticals, pharmacogenomic, biotechnical, and medical products and devices;
Q QUINTILES QUINTILES TRANSNATIONAL CORP. 4820 Emperor Boulevard Durham NC 27703 clinical research and testing services in the field of pharmaceutical, biotechnical and medical products and related consulting services;
QFAX Quintiles Transnational Corporation Post Office Box 13979 Research Triangle Park NC 277093979 clinical research and testing services, namely collecting and analyzing data via facsimile, in the field of pharmaceutical and medical products and related consultation services provided therewith;
QSTAR QUINTILES TRANSNATIONAL CORP. 4820 Emperor Boulevard Durham NC 27703 clinical research and testing services in the field of pharmaceutical, biotechnical and medical products and related consulting services;
QTONE Quintiles Transnational Corporation Post Office Box 13979 Research Triangle Park NC 277093979 clinical research and testing services, namely collecting and analyzing data via facsimile, in the field of pharmaceutical and medical products and related consultation services provided therewith;
QUINTILES IQVIA INC. 100 IMS Drive Parsippany NJ 07054 clinical research and testing services in the field of pharmaceutical, biotechnical and medical products and related consulting services;
REP Pharmakopius International plc Alexander House, Gatehampton Road Goring-on-Thames, Reading Berkshire RG8 OEN United Kingdom clinical research and testing services in the field of toxicology;
THE DIFFERENCE IS SIGNIFICANT QUINTILES TRANSNATIONAL CORP. 4820 Emperor Boulevard Durham NC 27703 clinical research and testing services in the field of pharmaceutical, biotechnical and medical products and related consulting services;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A system and method are provided that addresses the need for an improved microbiology validation system that monitors and validates clinical culture laboratory test results as they occur throughout the testing lifecycle of a clinical culture. Techniques are provided that consider the results of earlier performed tests when entering results for later performed tests so that inconsistent or wrong test results of a patient are not inadvertently released to a physician for review.